Plecka , P. 2016. Non-pegylated liposomal doxorubicin plus capecitabine as first-line treatment in metastatic breast cancer. OncoReview. 6, 4(24) (Oct. 2016), 193-198. DOI:https://doi.org/10.5604/01.3001.0009.5068.